Royal Bank of Canada’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $79K | Sell |
6,584
-3,246
| -33% | -$46.6K | ﹤0.01% | 5257 |
|
|
2025
Q4 | $152K | Sell |
9,830
-2,569
| -21% | -$47.2K | ﹤0.01% | 4950 |
|
|
2025
Q3 | $268K | Sell |
12,399
-57,041
| -82% | -$1.27M | ﹤0.01% | 4897 |
|
|
2025
Q2 | $1.54M | Buy |
69,440
+15,127
| +28% | +$336K | ﹤0.01% | 3510 |
|
|
2025
Q1 | $1.29M | Sell |
54,313
-48,722
| -47% | -$1.15M | ﹤0.01% | 3275 |
|
|
2024
Q4 | $2.18M | Sell |
103,035
-660
| -0.6% | -$17.3K | ﹤0.01% | 2965 |
|
|
2024
Q3 | $3.34M | Buy |
103,695
+2,806
| +3% | +$82.9K | ﹤0.01% | 2603 |
|
|
2024
Q2 | $2.4M | Buy |
100,889
+29,338
| +41% | +$753K | ﹤0.01% | 2772 |
|
|
2024
Q1 | $2.13M | Sell |
71,551
-20,203
| -22% | -$632K | ﹤0.01% | 2866 |
|
|
2023
Q4 | $2.94M | Buy |
91,754
+26,124
| +40% | +$758K | ﹤0.01% | 2713 |
|
|
2023
Q3 | $1.92M | Buy |
65,630
+4,436
| +7% | +$159K | ﹤0.01% | 2887 |
|
|
2023
Q2 | $2.75M | Buy |
61,194
+4,525
| +8% | +$173K | ﹤0.01% | 2583 |
|
|
2023
Q1 | $1.95M | Buy |
56,669
+10,660
| +23% | +$346K | ﹤0.01% | 2817 |
|
|
2022
Q4 | $1.28M | Buy |
46,009
+30,199
| +191% | +$800K | ﹤0.01% | 3288 |
|
|
2022
Q3 | $369K | Sell |
15,810
-22,269
| -58% | -$711K | ﹤0.01% | 4274 |
|
|
2022
Q2 | $1.1M | Sell |
38,079
-160
| -0.4% | -$6.99K | ﹤0.01% | 3414 |
|
|
2022
Q1 | $2.1M | Sell |
38,239
-25,943
| -40% | -$1.28M | ﹤0.01% | 3007 |
|
|
2021
Q4 | $3.43M | Sell |
64,182
-1,026
| -2% | -$47.6K | ﹤0.01% | 2677 |
|
|
2021
Q3 | $2.76M | Sell |
65,208
-46,278
| -42% | -$2.36M | ﹤0.01% | 2810 |
|
|
2021
Q2 | $7.43M | Buy |
111,486
+18,997
| +21% | +$1.03M | ﹤0.01% | 2019 |
|
|
2021
Q1 | $4.09M | Buy |
92,489
+80,296
| +659% | +$2.98M | ﹤0.01% | 2393 |
|
|
2020
Q4 | $354K | Sell |
12,193
-2,551
| -17% | -$63.5K | ﹤0.01% | 4418 |
|
|
2020
Q3 | $323K | Buy |
14,744
+7,734
| +110% | +$137K | ﹤0.01% | 4205 |
|
|
2020
Q2 | $81K | Sell |
7,010
-9,146
| -57% | -$100K | ﹤0.01% | 4980 |
|
|
2020
Q1 | $106K | Buy |
16,156
+10,769
| +200% | +$153K | ﹤0.01% | 4743 |
|
|
2019
Q4 | $85K | Buy |
5,387
+1,501
| +39% | +$17K | ﹤0.01% | 5174 |
|
|
2019
Q3 | $29K | Sell |
3,886
-1,864
| -32% | -$13.3K | ﹤0.01% | 5344 |
|
|
2019
Q2 | $47K | Buy |
5,750
+2,250
| +64% | +$22.4K | ﹤0.01% | 5314 |
|
|
2019
Q1 | $39K | Sell |
3,500
-34
| -1% | -$428 | ﹤0.01% | 5304 |
|
|
2018
Q4 | $34K | Buy |
3,534
+3,185
| +913% | +$42.7K | ﹤0.01% | 5309 |
|
|
2018
Q3 | $6K | Buy |
+349
| New | +$5.57K | ﹤0.01% | 6202 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 6731 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | +$16 | ﹤0.01% | 6742 |
|
|
2017
Q4 | – | Sell |
-2,735
| Closed | -$28K | – | 6840 |
|
|
2017
Q3 | $28K | Sell |
2,735
-7,809
| -74% | -$112K | ﹤0.01% | 5776 |
|
|
2017
Q2 | $240K | Buy |
10,544
+9,193
| +680% | +$189K | ﹤0.01% | 4243 |
|
|
2017
Q1 | $26K | Sell |
1,351
-1,993
| -60% | -$38.7K | ﹤0.01% | 5492 |
|
|
2016
Q4 | $53K | Sell |
3,344
-10,664
| -76% | -$177K | ﹤0.01% | 5222 |
|
|
2016
Q3 | $283K | Buy |
14,008
+2,946
| +27% | +$54.1K | ﹤0.01% | 4181 |
|
|
2016
Q2 | $198K | Buy |
11,062
+1,428
| +15% | +$21.2K | ﹤0.01% | 4411 |
|
|
2016
Q1 | $129K | Buy |
9,634
+366
| +4% | +$5.66K | ﹤0.01% | 4634 |
|
|
2015
Q4 | $190K | Buy |
+9,268
| New | +$177K | ﹤0.01% | 4552 |
|
Other funds holding SGRY
BCI
PCM
KSCM
VPM
VCM
Royal Bank of Canada's SGRY Position: Q1 2026 in Review
Royal Bank of Canada reduced its Surgery Partners (SGRY) stake by 33% in Q1 2026, selling an estimated $46.6K and leaving 6,584 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #5257.
Royal Bank of Canada first reported a position in SGRY in Q4 2015 and has held it in 40 quarters since. The position peaked at $7.43M in Q2 2021. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.
- Royal Bank of Canada held 6,584 shares of Surgery Partners worth $79K as of Q1 2026.
- Royal Bank of Canada sold 3,246 Surgery Partners shares in Q1 2026, an estimated $46.6K.
- Surgery Partners made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5257 holding.
- Royal Bank of Canada first reported a position in Surgery Partners in Q4 2015 and has held it in 40 quarters since.
- Royal Bank of Canada's Surgery Partners position peaked at $7.43M in Q2 2021.
- 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.